Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-03

Clinical Trial Update: Assessment of Fluticasone Propionate on Ocular Allergy Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated fluticasone propionate for ocular allergy symptoms in allergic rhinitis patients; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Allergic Rhinitis, Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-03